martes, 9 de junio de 2026

J&J spends $1 billion to enter KRAS race for cancer treatments Acquisition of Firefly Bio follows field-changing Revolution Medicines data

https://www.statnews.com/2026/06/08/johnson-and-johnson-firefly-cancer-kras-treatment/ By Jason MastJune 8, 2026 General Assignment Reporter

No hay comentarios: